Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SELF
3126
Global Self Storage
SELF
$58.1M
| $249K | ﹤0.01% |
58,000
+20,295
| +54% | +$88.8K |
|
3127
USA Compression Partners
USAC
$3.79B
| $249K | ﹤0.01% |
+13,737
| New | +$234K |
|
3128
First Trust Financials AlphaDEX Fund
FXO
$1.14B
| $248K | ﹤0.01% |
7,400
-17,400
| -70% | -$566K |
|
3129
VolitionRx Ltd
VNRX
$9.63M
| $248K | ﹤0.01% |
2,615
-745
| -22% | -$77.2K |
|
3130
SIFCO Industries
SIF
$160M
| $247K | ﹤0.01% |
62,600
+4,500
| +8% | +$12.7K |
|
3131
Traws Pharma
TRAW
$6.72M
| $247K | ﹤0.01% |
1,720
+1,598
| +1,310% | +$299K |
|
|
NURO
3132
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| $247K | ﹤0.01% |
7,172
-161
| -2% | -$4.66K |
|
|
FRTA
3133
DELISTED
Forterra, Inc
FRTA
| $247K | ﹤0.01% |
21,400
-6,900
| -24% | -$67.1K |
|
3134
Mind CTI
MNDO
$20.6M
| $246K | ﹤0.01% |
101,932
+19,115
| +23% | +$45.9K |
|
3135
MediciNova
MNOV
$66M
| $246K | ﹤0.01% |
+36,500
| New | +$274K |
|
|
RPT
3136
Rithm Property Trust
RPT
$97.2M
| $246K | ﹤0.01% |
2,864
-10,522
| -79% | -$934K |
|
|
APEN
3137
DELISTED
Apollo Endosurgery, Inc.
APEN
| $245K | ﹤0.01% |
85,900
+3,800
| +5% | +$11K |
|
|
STRR
3138
DELISTED
Star Equity Holdings
STRR
| $243K | ﹤0.01% |
18,704
| – | – |
|
|
BPMP
3139
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $243K | ﹤0.01% |
15,565
-6,094
| -28% | -$90.3K |
|
|
MRUS
3140
DELISTED
Merus
MRUS
| $242K | ﹤0.01% |
+17,200
| New | +$277K |
|
3141
Invesco Semiconductors ETF
PSI
$2.27B
| $242K | ﹤0.01% |
10,800
-1,200
| -10% | -$24.8K |
|
3142
Ring Energy
REI
$315M
| $242K | ﹤0.01% |
+91,600
| New | +$180K |
|
3143
Armata Pharmaceuticals
ARMP
$175M
| $241K | ﹤0.01% |
74,154
-1,500
| -2% | -$6.04K |
|
3144
El Pollo Loco
LOCO
$502M
| $241K | ﹤0.01% |
15,900
-21,400
| -57% | -$299K |
|
3145
Forestar Group
FOR
$1.47B
| $239K | ﹤0.01% |
11,480
-14,400
| -56% | -$281K |
|
|
TRVG
3146
trivago
TRVG
$378M
| $239K | ﹤0.01% |
+18,220
| New | +$277K |
|
|
BXG
3147
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
| $239K | ﹤0.01% |
+23,147
| New | +$227K |
|
3148
Loop Industries
LOOP
$35.3M
| $238K | ﹤0.01% |
24,000
+7,100
| +42% | +$76.4K |
|
|
MR
3149
DELISTED
Montage Resources Corporation Common Stock
MR
| $238K | ﹤0.01% |
+30,020
| New | +$157K |
|
3150
Arlo Technologies
ARLO
$1.57B
| $236K | ﹤0.01% |
+56,000
| New | +$193K |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.